NURIX THERAPEUTICS, INC.: cashflow_investing

Value{"amount": -257713000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2023-12-01 – 2024-11-30
Statuscurrent
EntityNURIX THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001549595-25-000016 · Open the official SEC filing →
Retrieved: 2026-08-19T15:43:20.797219+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001549595/cashflow-investing/2024-11-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/6da331bd-fbdb-41ec-b321-6ac98f2daf0b

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies